RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
GViewer not supported for the selected species.
G
APOB
apolipoprotein B
ISO
protein:increased expression:serum
RGD
PMID:18076041
RGD:2325763
NCBI chr14:86,624,209...86,669,175
Ensembl chr14:86,624,332...86,668,704
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
ISO
DNA:polymorphism:exon:rs2606345 (human)
RGD
PMID:19168589
RGD:2317210
NCBI chr26:8,753,236...8,759,378
Ensembl chr26:8,753,327...8,759,384
G
PPARD
peroxisome proliferator activated receptor delta
ISO
RGD
PMID:18497548
RGD:2324871
NCBI chr17:36,695,546...36,779,554
Ensembl chr17:36,695,494...36,779,577
G
DDR2
discoidin domain receptor tyrosine kinase 2
disease_progression
ISO
RGD
PMID:29043607
RGD:150429712
NCBI chr20:1,298,636...1,451,872
Ensembl chr20:1,299,574...1,359,674
G
LOC103238018
interferon-induced transmembrane protein 1
disease_progression
ISO
RGD
PMID:29043607
RGD:150429712
NCBI chr 1:128,309...129,543
G
SLC7A5
solute carrier family 7 member 5
disease_progression
ISO
RGD
PMID:24131658
RGD:151361287
NCBI chr 5:73,229,953...73,269,801
Ensembl chr 5:73,229,951...73,269,754
G
APOB
apolipoprotein B
susceptibility
ISO
DNA:polymorphisms:intron, exon:IVS6+360C>T, 56C>T (human)
RGD
PMID:18296645
RGD:2317550
NCBI chr14:86,624,209...86,669,175
Ensembl chr14:86,624,332...86,668,704
G
APOE
apolipoprotein E
susceptibility
ISO
DNA:SNP:intron:rs440446 (human)
RGD
PMID:18296645
RGD:2317550
NCBI chr 6:38,377,154...38,381,219
Ensembl chr 6:38,376,887...38,381,438
G
ATM
ATM serine/threonine kinase
ISO
ClinVar Annotator: match by term: Bile duct cancer
ClinVar
PMID:9887333 PMID:17124347 PMID:20077034 PMID:25741868 PMID:26635394 PMID:28492532 More...
NCBI chr 1:99,653,208...99,786,889
Ensembl chr 1:99,653,139...99,791,520
G
MLH1
mutL homolog 1
ISO
ClinVar Annotator: match by term: Bile duct cancer
ClinVar
PMID:15340264 PMID:17510385 PMID:18307539 PMID:19419416 PMID:22136435 PMID:22703879 PMID:24033266 PMID:24728327 PMID:25741868 PMID:28492532 More...
NCBI chr15:2,364,537...2,418,379
Ensembl chr15:2,364,738...2,418,393
G
MSH2
mutS homolog 2
ISO
ClinVar Annotator: match by term: Bile duct cancer
ClinVar
PMID:25741868 PMID:33357406
NCBI chr14:59,730,101...59,802,857
Ensembl chr14:59,729,789...59,802,819
G
PALB2
partner and localizer of BRCA2
ISO
ClinVar Annotator: match by term: Bile duct cancer
ClinVar
PMID:25741868 PMID:26467025 PMID:28492532 PMID:30287823
NCBI chr 5:21,322,952...21,358,363
Ensembl chr 5:21,322,975...21,358,198
G
PKD1
polycystin 1, transient receptor potential channel interacting
ISO
ClinVar Annotator: match by term: Bile duct cancer
ClinVar
PMID:12007219 PMID:16430766 PMID:17574468 PMID:25741868 PMID:26467025 PMID:27782177 More...
NCBI chr 5:1,985,165...2,031,518
Ensembl chr 5:1,983,632...2,015,551
G
STK11
serine/threonine kinase 11
ISO
ClinVar Annotator: match by term: Bile duct cancer
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 6:973,033...996,857
Ensembl chr 6:974,144...995,136
G
TJP1
tight junction protein 1
ISO
protein:decreased expression:bile duct
RGD
PMID:19184677
RGD:2325030
NCBI chr26:52,623,751...52,750,037
Ensembl chr26:52,622,743...52,749,950
G
MSLN
mesothelin
ISO
protein:increased expression:bile duct
RGD
PMID:17276942
RGD:2326059
NCBI chr 5:681,923...690,530
Ensembl chr 5:683,480...690,757
G
SLC7A5
solute carrier family 7 member 5
disease_progression
ISO
RGD
PMID:24890221
RGD:151361210
NCBI chr 5:73,229,953...73,269,801
Ensembl chr 5:73,229,951...73,269,754
G
ABCC2
ATP binding cassette subfamily C member 2
susceptibility
ISO
DNA:polymorphism:exon:c.3972C>T (human)
RGD
PMID:19451719
RGD:2317508
NCBI chr 9:92,826,423...92,902,389
Ensembl chr 9:92,841,818...92,902,265
G
ADRB2
adrenoceptor beta 2
ISO
protein:decreased expression:liver
RGD
PMID:16292515
RGD:2325640
NCBI chr23:51,445,920...51,447,942
Ensembl chr23:51,446,154...51,447,401
G
ALB
albumin
disease_progression
ISO
RGD
PMID:10776430 PMID:17545000 PMID:20431764
RGD:2325679 RGD:2325680 RGD:2325682
NCBI chr 7:21,872,036...21,890,095
Ensembl chr 7:21,876,132...21,891,407
G
ALOX5
arachidonate 5-lipoxygenase
ISO
protein:increased expression:bile duct
RGD
PMID:18507031
RGD:2317521
NCBI chr 9:41,085,257...41,145,760
Ensembl chr 9:41,085,361...41,145,331
G
ANXA2
annexin A2
disease_progression
ISO
RGD
PMID:20493868
RGD:2325728
NCBI chr26:23,100,000...23,147,687
Ensembl chr26:23,099,992...23,145,457
G
APC
APC regulator of WNT signaling pathway
ISO
DNA:loss of heterozygosity DNA:hypermethylation:promoter
RGD
PMID:10212000 PMID:15467712
RGD:2317198 RGD:2317205
NCBI chr23:15,992,437...16,135,117
Ensembl chr23:16,042,287...16,137,067
G
APOA1
apolipoprotein A1
ISO
protein:decreased expression:serum
RGD
PMID:19486127
RGD:2325756
NCBI chr 1:108,201,967...108,203,902
Ensembl chr 1:108,201,439...108,203,609
G
ARID1A
AT-rich interaction domain 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24185509
NCBI chr20:105,981,549...106,066,093
Ensembl chr20:105,981,290...106,065,672
G
ASPH
aspartate beta-hydroxylase
ISO
RGD
PMID:21898484
RGD:6902945
NCBI chr 8:57,378,019...57,599,812
Ensembl chr 8:57,375,894...57,565,259
G
ATG101
autophagy related 101
disease_progression
ISO
RGD
PMID:35592424
RGD:153350091
NCBI chr11:48,243,200...48,251,129
Ensembl chr11:48,243,216...48,251,371
G
BAP1
BRCA1 associated deubiquitinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24185509 PMID:25231345
NCBI chr22:13,765,510...13,774,866
Ensembl chr22:13,764,686...13,774,740
G
BIRC6
baculoviral IAP repeat containing 6
ameliorates
ISO
mRNA:increased expression:bile duct (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr14:74,879,597...75,138,462
Ensembl chr14:74,878,700...75,138,441
G
BRAF
B-Raf proto-oncogene, serine/threonine kinase
ISO
DNA:missense mutation:cds:p.V600E (human)
RGD
PMID:12692057
RGD:11073239
NCBI chr21:109,495,525...109,690,261
G
CXCL8
C-X-C motif chemokine ligand 8
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:18550579
NCBI chr 7:22,202,497...22,205,730
Ensembl chr 7:22,202,527...22,204,068
G
CXCR1
C-X-C motif chemokine receptor 1
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:18550579
NCBI chr10:104,052,709...104,056,388
Ensembl chr10:104,053,544...104,054,620
G
CYP24A1
cytochrome P450 family 24 subfamily A member 1
ISO
protein:increased expression:intrahepatic bile, extrahepatic bile duct (human)
RGD
PMID:23375797
RGD:151361187
NCBI chr 2:9,868,794...9,889,510
Ensembl chr 2:9,868,678...9,885,884
G
EGF
epidermal growth factor
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:18550579 PMID:25741868 PMID:28492532
NCBI chr 7:57,810,110...57,911,361
Ensembl chr 7:57,811,728...57,911,516
G
EGFR
epidermal growth factor receptor
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:18550579 PMID:24728327 PMID:25741868 PMID:28492532
NCBI chr21:3,664,622...3,853,492
Ensembl chr21:3,666,339...3,853,239
G
EPO
erythropoietin
ISO
mRNA, protein:increased expression:liver
RGD
PMID:23052842
RGD:10400912
NCBI chr28:12,487,222...12,491,986
Ensembl chr28:12,489,766...12,491,908
G
EPOR
erythropoietin receptor
ISO
mRNA, protein:increased expression:liver
RGD
PMID:23052842
RGD:10400912
NCBI chr 6:10,313,382...10,320,196
Ensembl chr 6:10,313,775...10,320,066
G
ERBB2
erb-b2 receptor tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16818635
NCBI chr16:66,435,488...66,464,993
Ensembl chr16:66,434,251...66,464,952
G
EZH2
enhancer of zeste 2 polycomb repressive complex 2 subunit
no_association disease_progression
ISO
DNA:SNPs: :g.148525904C>G, (rs2302427), g.148519011C>T (rs6464926), g.148517456T>G (rs17171119) (human) DNA:SNP: :g.148505302C>T (rs887569) (human)
RGD
PMID:24179546
RGD:126779604
NCBI chr21:117,380,518...117,515,224
Ensembl chr21:117,380,361...117,421,573
G
FASLG
Fas ligand
ISO
RGD
PMID:11029528
RGD:2317746
NCBI chr25:56,488,572...56,496,469
Ensembl chr25:56,489,417...56,496,251
G
FGF2
fibroblast growth factor 2
ISO
protein:increased expression:bile
RGD
PMID:11478488
RGD:2317765
NCBI chr 7:70,089,394...70,157,423
G
FGFR2
fibroblast growth factor receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26258846
NCBI chr 9:114,234,344...114,354,736
Ensembl chr 9:114,234,250...114,354,704
G
FSCN1
fascin actin-bundling protein 1
disease_progression
ISO
protein:increased expression:bile ducts
RGD
PMID:19721413
RGD:2317780
NCBI chr28:16,127,033...16,142,285
Ensembl chr28:16,127,015...16,142,337
G
GSTP1
glutathione S-transferase pi 1
treatment
ISO
human cell line in a mouse model DNA:hypermethylation:promoter
RGD
PMID:12805482 PMID:15467712
RGD:14401711 RGD:2317198
NCBI chr 1:6,676,897...6,679,936
G
HDAC6
histone deacetylase 6
ISO
protein:increased expression:liver:
RGD
PMID:23370327
RGD:9681560
NCBI chr X:45,927,625...45,951,636
Ensembl chr X:45,928,092...45,952,929
G
HGF
hepatocyte growth factor
ISO
protein:increased expression:serum mRNA, protein:increased expression: :
RGD
PMID:10827151 PMID:16974053
RGD:2317909 RGD:2317925
NCBI chr21:67,118,785...67,193,506
Ensembl chr21:67,120,722...67,193,504
G
HIF1A
hypoxia inducible factor 1 subunit alpha
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:12919954 PMID:18550579 PMID:22647679 PMID:24120591 PMID:25741868
NCBI chr24:38,873,830...38,927,657
Ensembl chr24:38,873,861...38,928,288
G
HNF1B
HNF1 homeobox B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:39887605
NCBI chr16:30,033,486...30,097,106
Ensembl chr16:30,036,766...30,097,088
G
IDH1
isocitrate dehydrogenase (NADP(+)) 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24185509
NCBI chr10:94,021,002...94,039,997
Ensembl chr10:94,020,818...94,039,975
G
IL10
interleukin 10
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:11121048 PMID:14657422 PMID:14657427 PMID:18550579 PMID:25741868 PMID:28492532 More...
NCBI chr25:22,590,389...22,595,877
Ensembl chr25:22,590,962...22,594,836
G
IL19
interleukin 19
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:11121048 PMID:14657422 PMID:14657427 PMID:18550579 PMID:25741868 PMID:28492532 More...
NCBI chr25:22,514,199...22,523,680
Ensembl chr25:22,514,559...22,520,499
G
IL1B
interleukin 1 beta
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:18550579
NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
G
IL1R2
interleukin 1 receptor type 2
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr14:5,672,434...5,708,270
Ensembl chr14:5,673,163...5,708,372
G
IL4R
interleukin 4 receptor
ISO
mRNA:increased expression:bile duct
RGD
PMID:18798553
RGD:2317263
NCBI chr 5:25,019,638...25,069,732
Ensembl chr 5:25,046,701...25,070,015
G
IL6
interleukin 6
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:9769329 PMID:10720087 PMID:11001912 PMID:11889177 PMID:12519862 PMID:12560873 PMID:12719374 PMID:15070960 PMID:15331795 PMID:15472205 PMID:16150725 PMID:16278864 PMID:17623760 PMID:18550579 More...
NCBI chr21:35,577,513...35,582,385
Ensembl chr21:35,577,939...35,582,237
G
INS
insulin
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr 1:1,965,128...1,969,090
G
KCND2
potassium voltage-gated channel subfamily D member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34418280
NCBI chr21:89,091,939...89,575,464
G
KIT
KIT proto-oncogene, receptor tyrosine kinase
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr 7:13,808,104...13,891,003
Ensembl chr 7:13,808,037...13,890,976
G
KMT2C
lysine methyltransferase 2C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561520
NCBI chr21:120,299,295...120,587,843
Ensembl chr21:120,301,188...120,587,137
G
KRAS
KRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8968066 PMID:22561520
NCBI chr11:24,963,396...25,010,747
Ensembl chr11:24,973,619...25,005,191
G
KRT7
keratin 7
ISO
RGD
PMID:18393293
RGD:2317308
NCBI chr11:48,379,460...48,394,638
Ensembl chr11:48,379,465...48,394,643
G
LOC103224275
glutathione S-transferase Mu 1
ISO
RGD
PMID:24049014
RGD:14700980
NCBI chr20:23,854,969...23,861,634
G
LOC103226354
cytochrome c
ISO
RGD
PMID:19788692
RGD:2317615
NCBI chr21:33,251,825...33,253,298
G
LOC103227060
serine protease 2
ISO
protein:increased expression:serum
RGD
PMID:8621252
RGD:2324908
NCBI chr21:111,650,502...111,656,688
Ensembl chr21:111,651,681...111,656,699
G
LOC103231165
isocitrate dehydrogenase (NADP(+)) 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24185509
NCBI chr29:8,633,429...8,650,744
Ensembl chr29:8,633,715...8,650,657
G
LOC103233851
mucin-16
ISO
associated with Opisthorchiasis;protein:increased expression:serum
RGD
PMID:1653472
RGD:2325142
NCBI chr 6:8,110,087...8,256,015
G
LOC103241787
mucin-6
ISO
protein:increased expression: :
RGD
PMID:10209489
RGD:2325167
NCBI chr 1:822,052...858,589
G
LOC103242066
mucin-4
disease_progression
ISO
protein:increased expression:bile duct
RGD
PMID:14752841 PMID:19082442
RGD:2303602 RGD:2324944
NCBI chr15:91,313,060...91,345,172
G
LOC103243509
neuroendocrine secretory protein 55
disease_progression
ISO
DNA:polymorphism:393T>C (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17356712 PMID:22561520
RGD:1601377
NCBI chr 2:5,233,893...5,303,433
Ensembl chr 2:5,233,874...5,249,192
G
MDM2
MDM2 proto-oncogene
disease_progression
ISO
protein:increased expression:intrahepatic bile duct (human)
RGD
PMID:15619210
RGD:2317417
NCBI chr11:64,434,203...64,465,490
Ensembl chr11:64,434,261...64,469,890
G
MET
MET proto-oncogene, receptor tyrosine kinase
disease_progression
ISO
protein:increased phosphorylation:liver, carcinoma (human) protein:increased expression:liver, biliary epithelium (rat)
RGD
PMID:14656942 PMID:16818635
RGD:2317578 RGD:2317601
NCBI chr21:85,370,574...85,486,405
Ensembl chr21:85,397,645...85,488,093
G
MFSD4A
major facilitator superfamily domain containing 4A
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr25:23,740,916...23,774,514
Ensembl chr25:23,743,360...23,774,451
G
MGMT
O-6-methylguanine-DNA methyltransferase
ISO
DNA:hypermethylation:promoter (human)
RGD
PMID:17550320
RGD:2317632
NCBI chr 9:122,089,768...122,376,320
G
MKI67
marker of proliferation Ki-67
disease_progression
ISO
RGD
PMID:12903495
RGD:2317705
NCBI chr 9:120,697,183...120,727,039
Ensembl chr 9:120,698,834...120,726,866
G
MMP2
matrix metallopeptidase 2
disease_progression
ISO
protein:increased expression:bile duct
RGD
PMID:15213623 PMID:19629755
RGD:2324667 RGD:2325769
NCBI chr 5:41,264,382...41,291,657
Ensembl chr 5:41,264,354...41,291,004
G
MMP9
matrix metallopeptidase 9
ISO
protein:increased expression:bile duct mRNA:increased expression:bile duct
RGD
PMID:15213623 PMID:16463672
RGD:2324667 RGD:2325856
NCBI chr 2:17,867,267...17,874,757
Ensembl chr 2:17,867,177...17,874,712
G
MSLN
mesothelin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14576474
NCBI chr 5:681,923...690,530
Ensembl chr 5:683,480...690,757
G
MTHFR
methylenetetrahydrofolate reductase
susceptibility
ISO
DNA:polymorphism (human)
RGD
PMID:17201138
RGD:2317119
NCBI chr20:119,987,667...120,003,611
Ensembl chr20:119,990,133...120,002,950
G
MUC1
mucin 1, cell surface associated
disease_progression
ISO
protein:increased expression:serum protein:increased secretion:bile mRNA:increased expression:bile duct protein:increased expression:bile duct:
RGD
PMID:15213623 PMID:18081149 PMID:19055478 PMID:19260467 PMID:19639217
RGD:2317986 RGD:2324622 RGD:2324638 RGD:2324664 RGD:2324667
NCBI chr20:8,641,701...8,646,739
Ensembl chr20:8,642,842...8,646,962
G
MUC2
mucin 2, oligomeric mucus/gel-forming
ISO
mRNA:decreased expression:bile duct
RGD
PMID:11680592
RGD:2324948
NCBI chr 1:893,554...926,854
G
MUC3A
mucin 3A, cell surface associated
ISO
mRNA:decreased expression:bile duct
RGD
PMID:11680592
RGD:2324948
G
MUC5AC
mucin 5AC, oligomeric mucus/gel-forming
disease_progression
ISO
mRNA:increased expression:bile duct protein:increased expression:serum
RGD
PMID:11680592 PMID:14508831
RGD:2324948 RGD:2324990
NCBI chr 1:981,515...1,018,242
G
MUC5B
mucin 5B, oligomeric mucus/gel-forming
ISO
mRNA:decreased expression:bile duct
RGD
PMID:11680592
RGD:2324948
NCBI chr 1:1,040,756...1,083,246
Ensembl chr 1:1,042,110...1,081,240
G
NAT2
N-acetyltransferase 2
ISO
DNA:polymorphisms (human)
RGD
PMID:15901993
RGD:2317172
NCBI chr 8:16,451,144...16,494,961
Ensembl chr 8:16,493,749...16,494,621
G
NCAM1
neural cell adhesion molecule 1
ISO
associated with hepatitis
RGD
PMID:12031086
RGD:2326079
NCBI chr 1:104,332,622...104,647,258
G
NOS2
nitric oxide synthase 2
ISO
protein:increased expression:bile duct CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16094703 PMID:16818635
RGD:2325280
NCBI chr16:21,533,011...21,576,645
Ensembl chr16:21,533,484...21,574,257
G
NOTCH1
notch receptor 1
ISO
protein:increased expression:cholangiocyte
RGD
PMID:15887117
RGD:2325330
NCBI chr12:1,656,815...1,707,566
Ensembl chr12:1,656,918...1,709,585
G
NR1H4
nuclear receptor subfamily 1 group H member 4
disease_progression
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:24255171
RGD:15090822
NCBI chr11:95,792,428...95,877,989
Ensembl chr11:95,792,996...95,878,293
G
OGG1
8-oxoguanine DNA glycosylase
disease_progression
ISO
DNA:loss of heterozygosity (human)
RGD
PMID:11260864 PMID:11866974
RGD:2317134 RGD:2317136
NCBI chr22:45,757,414...45,763,690
G
OSBP2
oxysterol binding protein 2
ISO
mRNA:increased expression:blood
RGD
PMID:21763455
RGD:41404644
NCBI chr19:13,576,331...13,817,628
Ensembl chr19:13,762,503...13,798,702
G
OSBPL7
oxysterol binding protein like 7
ISO
mRNA:increased expression:blood
RGD
PMID:21763455
RGD:41404644
NCBI chr16:68,208,121...68,222,684
G
PANX2
pannexin 2
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr19:32,662,350...32,671,536
G
PAWR
pro-apoptotic WT1 regulator
ISO
mRNA,protein:decreased expression:cholangiocyte:
RGD
PMID:20724592
RGD:9835357
NCBI chr11:75,132,547...75,219,633
Ensembl chr11:75,133,186...75,219,072
G
PBRM1
polybromo 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24185509
NCBI chr22:13,914,023...14,059,221
Ensembl chr22:13,913,285...14,055,254
G
PEG3
paternally expressed 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561520
NCBI chr 6:49,284,174...49,300,162
Ensembl chr 6:49,284,064...49,313,455
G
PES1
pescadillo ribosomal biogenesis factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34845814
NCBI chr19:13,453,184...13,469,115
Ensembl chr19:13,453,160...13,469,012
G
PIR
pirin
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr X:13,854,356...13,966,554
Ensembl chr X:13,854,236...13,966,506
G
PPIA
peptidylprolyl isomerase A
ameliorates
ISO
human cell line and construct in a mouse model
RGD
PMID:21871105
RGD:150429623
NCBI chr21:13,876,099...13,883,546
Ensembl chr21:13,876,099...13,883,462
G
PPP3CA
protein phosphatase 3 catalytic subunit alpha
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr 7:49,149,044...49,478,796
Ensembl chr 7:49,148,933...49,321,013
G
PREX2
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2
sexual_dimorphism
ISO
DNA:substitutions, insertion/deletions: (human)
RGD
PMID:28000796
RGD:151665188
NCBI chr 8:63,781,892...64,061,222
Ensembl chr 8:63,781,948...64,060,864
G
PRKACA
protein kinase cAMP-activated catalytic subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26258846
NCBI chr 6:12,743,752...12,759,155
G
PRKACB
protein kinase cAMP-activated catalytic subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26258846
NCBI chr20:49,109,774...49,273,200
Ensembl chr20:49,108,425...49,178,806
G
PRRG4
proline rich and Gla domain 4
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr 1:32,368,966...32,391,490
Ensembl chr 1:32,364,771...32,390,977
G
PRSS56
serine protease 56
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr10:118,538,752...118,545,759
Ensembl chr10:118,540,863...118,545,740
G
PTEN
phosphatase and tensin homolog
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:23376645 PMID:27022031
RGD:12802341
NCBI chr 9:81,308,058...81,412,386
Ensembl chr 9:81,309,099...81,409,146
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
NCBI chr25:42,733,535...42,742,463
Ensembl chr25:42,734,771...42,742,429
G
RASSF8
Ras association domain family member 8
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr11:25,709,062...25,826,507
Ensembl chr11:25,745,996...25,826,508
G
RNF39
ring finger protein 39
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr17:42,423,486...42,429,631
Ensembl chr17:42,424,126...42,428,787
G
RNF43
ring finger protein 43
exacerbates
ISO
CTD Direct Evidence: marker/mechanism associated with opisthorchiasis;DNA:SNPs:multiple: (human)
CTD RGD
PMID:22561520
RGD:151361227
NCBI chr16:34,981,126...35,046,478
Ensembl chr16:34,980,922...35,045,107
G
ROBO2
roundabout guidance receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561520
NCBI chr22:99,334,033...101,101,924
G
RUNX3
RUNX family transcription factor 3
ISO
protein:decreased expression:bile duct
RGD
PMID:19827872
RGD:2324955
NCBI chr20:107,769,244...107,802,154
Ensembl chr20:107,736,683...107,802,307
G
SLC4A4
solute carrier family 4 member 4
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr 7:19,581,399...20,043,334
G
SLC5A5
solute carrier family 5 member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17408651
NCBI chr 6:16,346,361...16,367,833
G
SLC7A5
solute carrier family 7 member 5
disease_progression treatment
ISO
RGD
PMID:24131658 PMID:25475870 PMID:28347255
RGD:151361214 RGD:151361287 RGD:151361294
NCBI chr 5:73,229,953...73,269,801
Ensembl chr 5:73,229,951...73,269,754
G
SMAD4
SMAD family member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561520
NCBI chr18:29,894,157...29,951,445
Ensembl chr18:29,897,621...29,934,478
G
SOCS3
suppressor of cytokine signaling 3
severity
ISO
protein:decreased expression:bile duct (human)
RGD
PMID:26485275
RGD:11250478
NCBI chr16:70,353,099...70,356,401
Ensembl chr16:70,354,746...70,355,423
G
SOX17
SRY-box transcription factor 17
severity
ISO
RGD
PMID:20816680
RGD:4889598
NCBI chr 8:50,523,816...50,527,360
Ensembl chr 8:50,524,893...50,527,847
G
SOX2
SRY-box transcription factor 2
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr15:7,673,581...7,676,812
Ensembl chr15:7,674,867...7,675,826
G
TGFB1
transforming growth factor beta 1
disease_progression
ISO
protein:increased expression:pancreas
RGD
PMID:12632524 PMID:16083599
RGD:1299231 RGD:2325020
NCBI chr 6:35,651,583...35,674,387
Ensembl chr 6:35,648,677...35,674,365
G
TGFBR2
transforming growth factor beta receptor 2
ISO
mRNA:increased expression:bile duct
RGD
PMID:12632524
RGD:1299231
NCBI chr15:75,112,903...75,200,263
Ensembl chr15:75,112,561...75,197,711
G
THBS1
thrombospondin 1
disease_progression
ISO
DNA:hypermethylation (human)
RGD
PMID:11927969 PMID:12213730 PMID:16465407
RGD:2325024 RGD:2325026 RGD:2325027
NCBI chr26:43,410,693...43,427,816
Ensembl chr26:43,410,580...43,427,812
G
TNC
tenascin C
severity
ISO
RGD
PMID:20816680
RGD:4889598
NCBI chr12:24,457,616...24,556,194
Ensembl chr12:24,457,738...24,556,451
G
TNFAIP3
TNF alpha induced protein 3
severity
ISO
protein:increased expression:bile duct (human)
RGD
PMID:26485275
RGD:11250478
NCBI chr13:35,537,103...35,553,396
Ensembl chr13:35,537,102...35,549,197
G
TP53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16818635 PMID:22561520
NCBI chr16:7,047,686...7,065,567
Ensembl chr16:7,045,146...7,066,223
G
TTR
transthyretin
ISO
protein:decreased expression:blood serum (human)
RGD
PMID:18275060
RGD:151660506
NCBI chr18:49,124,302...49,131,495
Ensembl chr18:49,124,121...49,131,399
G
VEGFA
vascular endothelial growth factor A
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:18550579
NCBI chr17:28,377,959...28,394,508
G
WDHD1
WD repeat and HMG-box DNA binding protein 1
ameliorates
ISO
RGD
PMID:30314946
RGD:156420141
NCBI chr24:32,118,688...32,204,464
Ensembl chr24:32,117,375...32,204,388
G
WNT9A
Wnt family member 9A
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr25:1,759,047...1,787,510
Ensembl chr25:1,781,826...1,788,663
G
BAP1
BRCA1 associated deubiquitinase 1
disease_progression
ISO
RGD
PMID:25536104
RGD:150340631
NCBI chr22:13,765,510...13,774,866
Ensembl chr22:13,764,686...13,774,740
G
PBRM1
polybromo 1
disease_progression
ISO
RGD
PMID:25536104
RGD:150340631
NCBI chr22:13,914,023...14,059,221
Ensembl chr22:13,913,285...14,055,254
G
RAC1
Rac family small GTPase 1
ISO
protein:increased expression:mucosa (human)
RGD
PMID:21537609
RGD:153350126
NCBI chr28:15,583,609...15,610,753
Ensembl chr28:15,583,516...15,610,328
G
SLC7A5
solute carrier family 7 member 5
disease_progression
ISO
RGD
PMID:24890221
RGD:151361210
NCBI chr 5:73,229,953...73,269,801
Ensembl chr 5:73,229,951...73,269,754
G
PKD1
polycystin 1, transient receptor potential channel interacting
ISO
ClinVar Annotator: match by term: Extrahepatic bile duct cancer
ClinVar
PMID:25741868
NCBI chr 5:1,985,165...2,031,518
Ensembl chr 5:1,983,632...2,015,551
G
XPO1
exportin 1
disease_progression
ISO
protein:increased expression:extrahepatic bile duct (human)
RGD
PMID:27279267
RGD:151665800
NCBI chr14:45,428,279...45,487,965
Ensembl chr14:45,432,619...45,488,723
G
CDK1
cyclin dependent kinase 1
ISO
protein:increased expression:gallbladder
RGD
PMID:15017593
RGD:2722465
NCBI chr 9:70,475,736...70,492,947
G
DDR2
discoidin domain receptor tyrosine kinase 2
disease_progression
ISO
RGD
PMID:29043607
RGD:150429712
NCBI chr20:1,298,636...1,451,872
Ensembl chr20:1,299,574...1,359,674
G
LOC103238018
interferon-induced transmembrane protein 1
disease_progression
ISO
RGD
PMID:29043607
RGD:150429712
NCBI chr 1:128,309...129,543
G
APC
APC regulator of WNT signaling pathway
disease_progression
ISO
DNA:SNP::rs11954856(human)
RGD
PMID:26715268
RGD:151356500
NCBI chr23:15,992,437...16,135,117
Ensembl chr23:16,042,287...16,137,067
G
APOB
apolipoprotein B
susceptibility
ISO
DNA:SNP: :rs693 (human)
RGD
PMID:17696941 PMID:20082485
RGD:2325761 RGD:2325764
NCBI chr14:86,624,209...86,669,175
Ensembl chr14:86,624,332...86,668,704
G
APOE
apolipoprotein E
susceptibility
ISO
DNA:SNP:intron:rs440446 (human)
RGD
PMID:18296645
RGD:2317550
NCBI chr 6:38,377,154...38,381,219
Ensembl chr 6:38,376,887...38,381,438
G
AXIN2
axin 2
disease_progression
ISO
DNA:SNP::s4791171(human)
RGD
PMID:26715268
RGD:151356500
NCBI chr16:55,874,043...55,906,739
Ensembl chr16:55,874,072...55,907,281
G
BRAF
B-Raf proto-oncogene, serine/threonine kinase
ISO
ClinVar Annotator: match by term: Gallbladder cancer
ClinVar
NCBI chr21:109,495,525...109,690,261
G
BUB1B
BUB1 mitotic checkpoint serine/threonine kinase B
ISO
mRNA:increased expression:gallbladder
RGD
PMID:18497548
RGD:2324871
NCBI chr26:42,769,955...42,855,353
Ensembl chr26:42,792,830...42,855,306
G
CALR
calreticulin
exacerbates
ISO
mRNA, protein:increased expression:gall bladder (human)
RGD
PMID:33591948
RGD:150521682
NCBI chr 6:11,618,691...11,624,299
Ensembl chr 6:11,618,396...11,623,792
G
CCR5
C-C motif chemokine receptor 5
onset
ISO
DNA:frameshift mutation:cds:p.S185_T195del rs333 (human)
RGD
PMID:18405329
RGD:2317570
NCBI chr22:7,803,794...7,818,112
G
CTNNB1
catenin beta 1
ISO
ClinVar Annotator: match by term: Gallbladder cancer
ClinVar
PMID:10435629 PMID:26822237
NCBI chr22:2,679,488...2,725,034
Ensembl chr22:2,684,022...2,723,949
G
CYP17A1
cytochrome P450 family 17 subfamily A member 1
susceptibility
ISO
DNA:transition:5' utr:-34T>C rs743572 (human)
RGD
PMID:16381022
RGD:2317619
NCBI chr 9:95,870,098...95,877,345
Ensembl chr 9:95,866,908...95,877,180
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
ISO
DNA:polymorphism: :p.I462V (human) DNA:transition: :6235T>C (human)
RGD
PMID:18287863 PMID:18990008
RGD:2317211 RGD:2317212
NCBI chr26:8,753,236...8,759,378
Ensembl chr26:8,753,327...8,759,384
G
DPYD
dihydropyrimidine dehydrogenase
disease_progression
ISO
RGD
PMID:16619549
RGD:2317631
NCBI chr20:35,376,738...36,215,388
Ensembl chr20:35,377,266...36,215,679
G
EGF
epidermal growth factor
susceptibility
ISO
DNA:SNP: :+61A>G (rs4444903)(human)
RGD
PMID:8093356 PMID:18571008
RGD:2317641 RGD:2317646
NCBI chr 7:57,810,110...57,911,361
Ensembl chr 7:57,811,728...57,911,516
G
GLI1
GLI family zinc finger 1
disease_progression
ISO
DNA:SNP::rs2228226(human)
RGD
PMID:26715268
RGD:151356500
NCBI chr11:53,371,929...53,384,339
Ensembl chr11:53,375,558...53,385,269
G
JUNB
JunB proto-oncogene, AP-1 transcription factor subunit
exacerbates
ISO
protein:increased expression:gall bladder (human)
RGD
PMID:26318166
RGD:11528126
NCBI chr 6:11,479,108...11,480,942
Ensembl chr 6:11,479,407...11,480,450
G
KEAP1
kelch like ECH associated protein 1
ISO
DNA:missense mutations, frameshift mutations:cds:multiple (human)
RGD
PMID:18692501
RGD:6893398
NCBI chr 6:9,515,789...9,526,699
Ensembl chr 6:9,515,416...9,522,797
G
KRAS
KRAS proto-oncogene, GTPase
ISO
ClinVar Annotator: match by term: Gallbladder cancer
ClinVar
PMID:6320174 PMID:11745231 PMID:15696205 PMID:16051643 PMID:17704260 PMID:25741868 PMID:26242988 PMID:28492532 PMID:31666701 PMID:35658005 More...
NCBI chr11:24,963,396...25,010,747
Ensembl chr11:24,973,619...25,005,191
G
LOC103224275
glutathione S-transferase Mu 1
ISO
RGD
PMID:26925680
RGD:14700928
NCBI chr20:23,854,969...23,861,634
G
LRP1B
LDL receptor related protein 1B
ameliorates
ISO
DNA:mutations:multiple: (human)
RGD
PMID:32898339
RGD:150429787
NCBI chr10:25,611,400...27,511,903
Ensembl chr10:25,616,590...26,609,111
G
PIK3CA
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
ISO
ClinVar Annotator: match by term: Gallbladder cancer
ClinVar
PMID:15520168 PMID:15608678 PMID:15930273 PMID:17673550 PMID:21078999 PMID:22658544 PMID:22729223 PMID:22729224 PMID:23946963 PMID:25599672 PMID:25741868 PMID:25880439 PMID:26627007 PMID:26637981 PMID:27631024 PMID:28151489 PMID:28425981 PMID:29661094 PMID:30376034 PMID:30543347 PMID:31536475 PMID:37712948 More...
NCBI chr15:10,218,034...10,304,874
Ensembl chr15:10,218,805...10,294,316
G
RBP4
retinol binding protein 4
disease_progression
ISO
associated with type 2 diabetes mellitus; protein:decreased expression:blood serum (human)
RGD
PMID:37273108
RGD:329849105
NCBI chr 9:86,831,042...86,840,668
Ensembl chr 9:86,830,957...86,840,250
G
RICTOR
RPTOR independent companion of MTOR complex 2
ISO
DNA:CNV, amplification:exon (human)
RGD
PMID:24508317
RGD:152995522
NCBI chr 4:37,758,531...37,885,323
Ensembl chr 4:37,762,901...37,873,766
G
SMAD4
SMAD family member 4
ISO
ClinVar Annotator: match by term: Gallbladder cancer
ClinVar
PMID:10479724 PMID:10764709 PMID:16152648 PMID:16436638 PMID:21465659 PMID:22810475 PMID:23239472 PMID:25931195 PMID:26467025 PMID:26689913 PMID:28492532 PMID:30851333 PMID:31949278 PMID:32561076 PMID:32719554 PMID:34393517 PMID:35982159 PMID:36158166 PMID:36451132 PMID:37319387 More...
NCBI chr18:29,894,157...29,951,445
Ensembl chr18:29,897,621...29,934,478
G
TP53
tumor protein p53
ISO
ClinVar Annotator: match by term: Gallbladder cancer
ClinVar
PMID:1631137 PMID:1978757 PMID:7478555 PMID:7791795 PMID:8023157 PMID:8062826 PMID:8099841 PMID:8276238 PMID:8425176 PMID:8527048 PMID:8688334 PMID:9150393 PMID:9242456 PMID:9598730 PMID:9825943 PMID:10089074 PMID:11051239 PMID:11370630 PMID:11782540 PMID:11793474 PMID:12406399 PMID:12506399 PMID:12826609 PMID:14673037 PMID:14743206 PMID:15925506 PMID:15993273 PMID:16199547 PMID:16818505 PMID:16861262 PMID:16969106 PMID:17390010 PMID:17417627 PMID:17427234 PMID:17567834 PMID:17572079 PMID:17606709 PMID:17881637 PMID:18978813 PMID:19378321 PMID:19556618 PMID:19711436 PMID:19714490 PMID:20013323 PMID:20128691 PMID:20182602 PMID:20407015 PMID:20436704 PMID:20522432 PMID:21059199 PMID:21305319 PMID:21343334 PMID:21519010 PMID:21601526 PMID:21665182 PMID:21761402 PMID:22186996 PMID:22265402 PMID:22713868 PMID:22915647 PMID:22955915 PMID:23172776 PMID:23246812 PMID:23667202 PMID:23894400 PMID:23950206 PMID:24033266 PMID:24038938 PMID:24382691 PMID:24573247 PMID:24603336 PMID:24651015 PMID:25157968 PMID:25293557 PMID:25544776 PMID:25587027 PMID:25741868 PMID:25925845 PMID:25952993 PMID:26230955 PMID:26425688 PMID:26467025 PMID:26585234 PMID:26619011 PMID:26718964 PMID:26787237 PMID:26911350 PMID:27276561 PMID:27374712 PMID:27463065 PMID:27680515 PMID:27895058 PMID:27959731 PMID:28160093 PMID:28369373 PMID:28472496 PMID:28492532 PMID:28724667 PMID:28861920 PMID:28975465 PMID:29025599 PMID:29324801 PMID:29752822 PMID:29979965 PMID:30224644 PMID:30322717 PMID:30327374 PMID:30720243 PMID:31105275 PMID:31127191 PMID:31742824 PMID:31775759 PMID:32187361 PMID:32817165 PMID:33300245 PMID:33471991 PMID:34240179 PMID:36988593 More...
NCBI chr16:7,047,686...7,065,567
Ensembl chr16:7,045,146...7,066,223
G
XRCC1
X-ray repair cross complementing 1
susceptibility
ISO
DNA:polymorphisms: :p.R194W, p.R399Q (human)
RGD
PMID:19266243
RGD:2317128
NCBI chr 6:37,062,149...37,095,138
Ensembl chr 6:37,060,439...37,095,094
G
ABO
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
ISO
RGD
PMID:7795450
RGD:2317512
NCBI chr12:4,863,100...4,892,204
Ensembl chr12:4,863,165...4,885,849
G
ACTR3
actin related protein 3
severity
ISO
Squamous Cell/Adenosquamous Carcinoma and Adenocarcinoma;protein:increased expression:gall bladder (human)
RGD
PMID:23320827
RGD:11571623
NCBI chr10:16,296,350...16,369,561
Ensembl chr10:16,297,502...16,369,220
G
ANTXR1
ANTXR cell adhesion molecule 1
severity
ISO
RGD
PMID:21545221
RGD:9684943
NCBI chr14:37,849,911...38,116,339
Ensembl chr14:37,877,436...38,115,938
G
BIRC3
baculoviral IAP repeat containing 3
exacerbates
ISO
mRNA:increased expression:gall bladder (human)
RGD
PMID:28295868
RGD:153297817
NCBI chr 1:93,692,239...93,711,905
G
CFL1
cofilin 1
severity
ISO
Squamous Cell/Adenosquamous Carcinoma and Adenocarcinoma;protein:increased expression:gall bladder (human)
RGD
PMID:23320827
RGD:11571623
NCBI chr 1:8,408,560...8,410,564
G
CLPTM1L
CLPTM1 like
susceptibility
ISO
DNA:SNP, haplotype: :rs401681(human)
RGD
PMID:29450669
RGD:150530629
NCBI chr 4:1,140,272...1,162,663
Ensembl chr 4:1,140,132...1,162,898
G
GPX3
glutathione peroxidase 3
severity
ISO
protein:decreased expression:gallbladder (human)
RGD
PMID:24167362
RGD:151665515
NCBI chr23:53,576,950...53,585,321
G
IL10
interleukin 10
susceptibility
ISO
associated with Cholelithiasis
RGD
PMID:19065724
RGD:2317654
NCBI chr25:22,590,389...22,595,877
Ensembl chr25:22,590,962...22,594,836
G
LOC103219825
protein patched homolog 1
disease_progression
ISO
RGD
PMID:22407314
RGD:150523794
NCBI chr12:107,580,895...107,656,443
Ensembl chr12:107,590,663...107,652,985
G
MTUS1
microtubule associated scaffold protein 1
disease_progression
ISO
RGD
PMID:31882471
RGD:25330344
NCBI chr 8:15,739,220...15,899,834
Ensembl chr 8:15,741,294...15,853,293
G
RAC1
Rac family small GTPase 1
exacerbates
ISO
protein:increased expression:gallbladder (human)
RGD
PMID:21853342
RGD:155230819
NCBI chr28:15,583,609...15,610,753
Ensembl chr28:15,583,516...15,610,328
G
TERT
telomerase reverse transcriptase
susceptibility
ISO
DNA:SNP, haplotype: :rs2736100(human)
RGD
PMID:29450669
RGD:150530629
NCBI chr 4:1,082,894...1,119,373
Ensembl chr 4:1,083,384...1,117,468
G
TGFA
transforming growth factor alpha
ISO
RGD
PMID:9542514
RGD:2317470
NCBI chr14:36,545,641...36,654,213
Ensembl chr14:36,545,875...36,648,237
G
TJP1
tight junction protein 1
ISO
protein:decreased expression:gallbladder
RGD
PMID:19184677
RGD:2325030
NCBI chr26:52,623,751...52,750,037
Ensembl chr26:52,622,743...52,749,950
G
TYMP
thymidine phosphorylase
disease_progression
ISO
RGD
PMID:18946757
RGD:2325157
NCBI chr19:32,997,337...33,001,558
Ensembl chr19:32,997,304...33,001,215
G
UBR5
ubiquitin protein ligase E3 component n-recognin 5
ameliorates
ISO
human cell line in a mouse model
RGD
PMID:30775814
RGD:151665192
NCBI chr 8:97,104,325...97,257,317
Ensembl chr 8:97,103,220...97,257,440
G
APC
APC regulator of WNT signaling pathway
ISO
ClinVar Annotator: match by term: Intrahepatic cholangiocarcinoma
ClinVar
PMID:24728327 PMID:25479140 PMID:25741868 PMID:26467025 PMID:26530882 PMID:28135048 PMID:28195569 PMID:28492532 PMID:32390703 More...
NCBI chr23:15,992,437...16,135,117
Ensembl chr23:16,042,287...16,137,067
G
ARID1A
AT-rich interaction domain 1A
disease_progression exacerbates
ISO
mRNA,protein:decreased expression:intrahepatic bile duct (human)
RGD
PMID:27433094 PMID:30849962 PMID:31665232
RGD:126775257 RGD:126781775 RGD:14974231
NCBI chr20:105,981,549...106,066,093
Ensembl chr20:105,981,290...106,065,672
G
BAP1
BRCA1 associated deubiquitinase 1
disease_progression
ISO
RGD
PMID:27864835
RGD:150340628
NCBI chr22:13,765,510...13,774,866
Ensembl chr22:13,764,686...13,774,740
G
BECN1
beclin 1
disease_progression
ISO
RGD
PMID:30849962
RGD:14974231
NCBI chr16:63,469,187...63,482,627
Ensembl chr16:63,469,192...63,485,322
G
BRAF
B-Raf proto-oncogene, serine/threonine kinase
severity
ISO
DNA:missense mutation:cds:p.V600E (human)
RGD
PMID:24139215
RGD:14398746
NCBI chr21:109,495,525...109,690,261
G
FASLG
Fas ligand
severity
ISO
RGD
PMID:11003620
RGD:14700701
NCBI chr25:56,488,572...56,496,469
Ensembl chr25:56,489,417...56,496,251
G
FOXP3
forkhead box P3
ISO
DNA:hypomethylation:liver
RGD
PMID:24291052
RGD:38599002
NCBI chr X:46,349,890...46,365,133
G
HSP90AA1
heat shock protein 90 alpha family class A member 1
disease_progression
ISO
protein:increased expression:liver (human)
RGD
PMID:24796583
RGD:152177907
NCBI chr24:80,016,352...80,019,130
Ensembl chr24:80,016,232...80,019,120
G
HSP90AB1
heat shock protein 90 alpha family class B member 1
disease_progression
ISO
protein:increased expression:liver (human)
RGD
PMID:24796583
RGD:152177907
NCBI chr17:27,914,261...27,921,666
Ensembl chr17:27,911,013...27,921,251
G
IDH1
isocitrate dehydrogenase (NADP(+)) 1
no_association
ISO
DNA:misssense mutations:cds:p.Arg132Cys,Arg132Leu (human)
RGD
PMID:26245674
RGD:14974229
NCBI chr10:94,021,002...94,039,997
Ensembl chr10:94,020,818...94,039,975
G
KDM5C
lysine demethylase 5C
exacerbates
ISO
protein:decreased expression:bile duct (human)
RGD
PMID:32714863
RGD:151361175
NCBI chr X:49,306,472...49,356,151
Ensembl chr X:49,321,173...49,356,100
G
KRAS
KRAS proto-oncogene, GTPase
disease_progression
ISO
DNA:mutations::
RGD MouseDO
PMID:24139215
RGD:14398746
NCBI chr11:24,963,396...25,010,747
Ensembl chr11:24,973,619...25,005,191
G
LCN2
lipocalin 2
treatment
ISO
Protein:increased expression:bile duct
RGD
PMID:24939880
RGD:126790491
NCBI chr12:9,976,278...9,981,087
Ensembl chr12:9,976,614...9,980,870
G
LOC103231165
isocitrate dehydrogenase (NADP(+)) 2
disease_progression
ISO
DNA:mutations: : mRNA:decreased expression:liver (mouse)
RGD
PMID:22824796 PMID:32463951
RGD:149735894 RGD:14985256
NCBI chr29:8,633,429...8,650,744
Ensembl chr29:8,633,715...8,650,657
G
LRP1B
LDL receptor related protein 1B
exacerbates
ISO
DNA:mutations:multiple: (human)
RGD
PMID:33014052
RGD:150429786
NCBI chr10:25,611,400...27,511,903
Ensembl chr10:25,616,590...26,609,111
G
MAGI1
membrane associated guanylate kinase, WW and PDZ domain containing 1
disease_progression
ISO
protein:increased expression:intrahepatic bile duct (human)
RGD
PMID:30377796
RGD:152998946
NCBI chr22:26,383,310...27,057,081
Ensembl chr22:26,384,511...26,645,528
G
PBRM1
polybromo 1
disease_progression
ISO
protein:increased expression:intrahepatic bile duct (human)
RGD
PMID:27864835 PMID:30377796
RGD:150340628 RGD:152998946
NCBI chr22:13,914,023...14,059,221
Ensembl chr22:13,913,285...14,055,254
G
PTEN
phosphatase and tensin homolog
disease_progression
ISO
protein:decreased expression:liver (human)
RGD
PMID:24796583
RGD:152177907
NCBI chr 9:81,308,058...81,412,386
Ensembl chr 9:81,309,099...81,409,146
G
RNF43
ring finger protein 43
exacerbates
ISO
mRNA, protein:decreased expression:liver, bile duct epithelium (human)
RGD
PMID:26980022
RGD:151361125
NCBI chr16:34,981,126...35,046,478
Ensembl chr16:34,980,922...35,045,107
G
S100B
S100 calcium binding protein B
disease_progression
ISO
protein:increased expression:intrahepatic bile duct (human)
RGD
PMID:30377796
RGD:152998946
NCBI chr 2:90,188,820...90,194,986
Ensembl chr 2:90,188,639...90,195,023
G
SMAD4
SMAD family member 4
disease_progression
ISO
mRNA,protein:decreased expression:intrahepatic bile duct
RGD
PMID:16917866 PMID:23981608
RGD:18936999 RGD:21066336
NCBI chr18:29,894,157...29,951,445
Ensembl chr18:29,897,621...29,934,478
G
TEP1
telomerase associated protein 1
ISO
mRNA:increased expression:hepatocyte,biliary epithelium.
RGD
PMID:10498642
RGD:152977753
NCBI chr29:20,880,255...20,928,874
Ensembl chr29:20,883,678...20,923,313
G
APC
APC regulator of WNT signaling pathway
ISO
ClinVar Annotator: match by term: Klatskin tumor
ClinVar
PMID:25741868 PMID:28492532
NCBI chr23:15,992,437...16,135,117
Ensembl chr23:16,042,287...16,137,067
G
ARID1A
AT-rich interaction domain 1A
disease_progression
ISO
DNA:deletions
RGD
PMID:33387086
RGD:126848756
NCBI chr20:105,981,549...106,066,093
Ensembl chr20:105,981,290...106,065,672
G
GATA6
GATA binding protein 6
sexual_dimorphism
ISO
DNA:mutations
RGD
PMID:33387086
RGD:126848756
NCBI chr18:58,312,328...58,345,472
Ensembl chr18:58,311,482...58,343,746
G
KMT2C
lysine methyltransferase 2C
onset
ISO
DNA:mutations
RGD
PMID:33387086
RGD:126848756
NCBI chr21:120,299,295...120,587,843
Ensembl chr21:120,301,188...120,587,137
G
KRAS
KRAS proto-oncogene, GTPase
disease_progression
ISO
DNA:mutations
RGD
PMID:33387086
RGD:126848756
NCBI chr11:24,963,396...25,010,747
Ensembl chr11:24,973,619...25,005,191
G
PREX2
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2
sexual_dimorphism
ISO
DNA:substitutions, insertion/deletions: (human)
RGD
PMID:33387086
RGD:126848756
NCBI chr 8:63,781,892...64,061,222
Ensembl chr 8:63,781,948...64,060,864
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all